2m 2m 2m 2m 2m 2m 2m
ELOXX PHARMACT (ELOX)
NASDAQ
$21.97+$0.99 (+4.72%)
Price as of Aug 24, 2026 9:02 AM EDT- $72.1MMarket Cap
- 190,681,718.18%1-Year Change
- BiotechnologyIndustry
ELOXX PHARMACT (ELOX)
$21.97+$0.99 (+4.72%)
ELOX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $20.98 | ||
Change | +$2.94 (+16.27%) | ||
Open | $19.00 | ||
High | $23.40 | ||
Low | $18.04 | ||
Previous Close | $18.04 | ||
Volume | 93,391 | ||
30-Day Average Volume | 64,725 | ||
1-Week Change | 11.81% | ||
1-Month Change | 74.79% | ||
1-Year Change | 190,681,718.18% | ||
3-Year Change | -60.60% | ||
5-Year Change | -96.71% | ||
Fundamentals | |||
Shares Outstanding | 3.4M | ||
Total Assets | $63.4M | ||
Market Cap | $72.1M | ||
Enterprise Value | $12.5M | ||
Period: QTR TTM FY | |||
Revenue | $0.00 | ||
Net Income | -$4.5M | ||
Free Cash Flow | -$4.8M | ||
EBIT | -$4.5M | ||
EBITDA | -$4.5M | ||
Net Working Capital | $46.4M | ||
EPS | -$0.66 | ||
Enterprise Value/EBITDA | -3 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 2 | ||
P/E | -32 | ||
PEG | 0 | ||
Price/Free Cash Flow | -15 | ||
Price/Operating Cash Flow | -15 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 11 | ||
Last Split Date | 06/01/2026 | ||
Earnings & Revenue